Pemphigus
Symptoms, Doctors, Treatments, Advances & More

Learn About Pemphigus

What is the definition of Pemphigus?
Pemphigus is a group of rare autoimmune diseases that cause blistering of the skin and mucous membranes (mouth, nose, throat, eyes, and genitals). This condition can occur at any age, but often strikes people in middle or older age. Studies have shown that some populations may be at greater risk for certain types of Pemphigus. For instance, people of Jewish descent and those from India, Southeast Europe, and the Middle East are at greater risk for Pemphigus vulargis, while Pemphigus foliaceus is more common in North America, Turkey, and South America.
What are the alternative names for Pemphigus?
  • Pemphigus
Who are the top Pemphigus Local Doctors?
Elite in Pemphigus
Elite in Pemphigus
Referral may be required

UCI Health Dermatology Center

850 Health Sciences Road, Floor 2, 
Irvine, CA 
Languages Spoken:
English, Russian
Accepting New Patients
Offers Telehealth

Sergei Grando is a Dermatologist practicing medicine in Irvine, California. Dr. Grando is rated as an Elite provider by MediFind in the treatment of Pemphigus. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid. Dr. Grando is board certified in American Board Of Dermatology - Dermatology. Dr. Grando is currently accepting new patients.

Elite in Pemphigus
Dermatology
Elite in Pemphigus
Dermatology
Referral required

Emory Clinic At 1525 Clifton Road

1525 Clifton Road Northeast, Fl3, 
Atlanta, GA 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Ron Feldman is a Dermatologist practicing medicine in Atlanta, Georgia. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Pemphigus. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus Foliaceus, Pemphigus, and Pemphigus Vulgaris. Dr. Feldman is board certified in American Board Of Dermatology, 2010. Dr. Feldman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pemphigus
Dermatology
Elite in Pemphigus
Dermatology
Referral may be required

Rush University Medical Center

1725 W Harrison St Ste 264, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kyle Amber is a Dermatologist practicing medicine in Chicago, Illinois. Dr. Amber is rated as an Elite provider by MediFind in the treatment of Pemphigus. He is also highly rated in 91 other conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus, Pemphigus Vulgaris, and Cicatricial Pemphigoid. Dr. Amber is currently accepting new patients.

What are the latest Pemphigus Clinical Trials?
A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CD19 CAR-T Cell Therapy in Patients With Moderate-to-Severe Refractory Pemphigus Vulgaris

Summary: This is an investigator-initiated, single-center, single-arm, open-label exploratory clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of autologous CD19 CAR-T cell therapy in patients with refractory pemphigus vulgaris.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Evaluation of the Effectiveness of Clobetasol Propionate 0.05% and Photobiomodulation in the Management of Oral Lesions in Patients With Pemphigus Vulgaris. (Three-arm Randomized Controlled Clinical Study)

Summary: Pemphigus vulgaris (PV) is a chronic, potentially life-threatening autoimmune mucocutaneous disorder that significantly impairs patients' quality of life. While systemic corticosteroids and immunosuppressants remain the standard of care, many patients suffer from persistent, painful oral lesions that exhibit delayed healing or poor response to conventional systemic protocols. This clinical trial i...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center